Swartz Robin 4
4 · Voyager Therapeutics, Inc. · Filed Dec 26, 2024
Insider Transaction Report
Form 4
Swartz Robin
COO & CBO
Transactions
- Sale
Common Stock
2024-12-23$5.65/sh−6,500$36,725→ 112,328 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.62 to $5.70, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Includes 1,824 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan on June 28, 2024.